In last trading session, Salarius Pharmaceuticals Inc (NASDAQ:SLRX) saw 0.32 million shares changing hands with its beta currently measuring 0.90. Company’s recent per share price level of $1.55 trading at $0.14 or 9.93% at ring of the bell on the day assigns it a market valuation of $2.23M. That closing price of SLRX’s stock is at a discount of -364.52% from its 52-week high price of $7.20 and is indicating a premium of 21.29% from its 52-week low price of $1.22. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 55580.0 shares which gives us an average trading volume of 320.73K if we extend that period to 3-months.
Salarius Pharmaceuticals Inc (NASDAQ:SLRX) trade information
Upright in the green during last session for gaining 9.93%, in the last five days SLRX remained trading in the green while hitting it’s week-highest on Thursday, 12/19/24 when the stock touched $1.55 price level, adding 4.32% to its value on the day. Salarius Pharmaceuticals Inc’s shares saw a change of -70.19% in year-to-date performance and have moved 5.45% in past 5-day. Salarius Pharmaceuticals Inc (NASDAQ:SLRX) showed a performance of 10.71% in past 30-days. Number of shares sold short was 65040.0 shares which calculate 0.08 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 64.97% during past 5 years.
Salarius Pharmaceuticals Inc (NASDAQ:SLRX)’s Major holders
Insiders are in possession of 2.52% of company’s total shares while institution are holding 0.36 percent of that, with stock having share float percentage of 0.37%. Investors also watch the number of corporate investors in a company very closely, which is 0.36% institutions for Salarius Pharmaceuticals Inc that are currently holding shares of the company.
